Pediatric and Adolescent Considerations for the Revised ASCO Guidelines

Lillian R Meacham¹, Tyler G Ketterl¹, Kari L Bjornard¹+9

• ¹Lillian R. Meacham, MD, Children's Healthcare of Atlanta/Emory University, Atlanta, GA; Tyler G. Ketterl, MD, MS, Seattle Children's Hospital/University of Washington, Seattle, WA; Kari L. Bjornard, MD, MPH, St Jude Children's Research Hospital, Memphis, TN; Leena Nahata, MD, Nationwide Children's Hospital/The Ohio State University College of Medicine, Columbus, OH; Veronica Gomez-Lobo, MD, Eunice Kennedy Shriver National Institute of Child Health and Human Development/National Institute of Health, Bethesda, MD; Allison G. Close, MD, MS, Helen DeVos Children's Hospital/Michigan State University, Grand Rapids, MI; Seth J. Rotz, MD, Cleveland Clinic/Lerner College of Medicine of Case Western Reserve University, Cleveland, OH; Maggie L. Dwiggins, MD, MS, Washington University in Saint Louis, St Louis, MO; Holly R. Hoefgen, MD, Washington University School of Medicine, St Louis, MO; Anthony Kayiira, MD, MSc, MMed, EMB, Uganda Cancer Institute/Uganda Childhood Cancer Foundation, Kampala, Uganda; and Marry van den Heuvel-Eibrink, MD, Princess Maxima Center for Pediatric Oncology/Utrecht University, Utrecht, the Netherlands.